The Western Blotting Market size is projected to reach US$ 1,173.73 million by 2031 from US$ 782.42 million in 2023. The market is expected to register a CAGR of 5.2% in 2023–2031. The increasing prevalence of HIV infection and technological advancements in botting systems and government initiatives along with investment by pharma and biotechnology companies is likely to remain key Western Blotting market trends.
According to the data published by the World Health Organization in 2022, approximately 39 million people are living with HIV of which 6,30,000 people died of Human Immunodeficiency Virus (HIV)-related illness. Hence, the rising prevalence of HIV has led to huge demand for western blotting tests. Western blotting test is always preferred over the enzyme-linked immunosorbent assay (ELISA) test for detecting HIV, owing to its greater accuracy in detecting HIV antibodies in the patient’s blood. However, ELISA is prescribed by healthcare professionals for HIV screening. The technique helps in confirming the HIV infection in the patient’s body. Although this testing tool is much more complicated as compared to ELISA, it delivers more accurate and effective results in detecting HIV.
North America is the largest market for Western Blotting market growth with the US holding the largest market share followed by Canada. Factors such as the increasing prevalence of HIV, increased R&D investment by pharma and biotechnology companies, and increasing application of western blotting technique, which is anticipated to further propel the overall North American Western Blotting market. For instance, in 2021, there were approximately 32,100 estimated new HIV infections in the U.S., however, the Southern US reported the highest percentage of HIV infection i.e. 52%, with approximately 16,700 cases among the newly estimated cases.
The increasing prevalence of HIV and Lyme disease is contributing to the demand for Western blotting. Western blotting is being used increasingly to effectively differentiate between HIV and other antibodies. For instance, according to the data published by Global HIV & AIDS Statistics, 2021, approximately, 1.5 million people became newly infected with HIV in 2021. A higher prevalence of such diseases requires more diagnostic tests and in turn drives the overall market growth.
Western blotting is a widely known and used test that is used in cell and molecular biology and has gained attraction in the market due to its low cost, specificity, and ease of use. Western blotting manufacturers have marked their presence in the market as there is consistent demand from pharmaceutical and biotechnology companies. Additionally, the research and development activities in the field of proteomics are acting as an additional catalyst for the growth of industrial players in this market.
Protein research dynamics, increased investments in proteomics by biotech and pharmaceutical companies as there is a huge demand for western blotting techniques. Hence, these factors are anticipated to offer lucrative opportunities for the western blotting market growth.
Key segments that contributed to the derivation of the Western Blotting Market analysis are product, application, and end users.
The geographic scope of the Western Blotting Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
North America has dominated the Western Blotting Market. The market growth can be attributed to the rising adoption of Western Blotting for various applications, the rising prevalence of HIV cases, the presence of major manufacturers involved in manufacturing western blotting systems, and the investment by pharma and biotech companies for medical devices in North American countries.
The regional trends and factors influencing the Western Blotting Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Western Blotting Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 782.42 Million |
| Market Size by 2031 | US$ 1,173.73 Million |
| Global CAGR (2023 - 2031) | 5.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Western Blotting Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Western Blotting Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Western Blotting Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for western blotting:
![](data:image/svg+xml;charset=utf-8,<svg height="60px" width="170px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="500px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="320px" width="500px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)